FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.69M | 1.97M | 2.12M | 2.28M | 2.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.20M | 2.52M | 2.98M | 3.01M | 3.19M |
| Operating Income | -2.20M | -2.52M | -2.98M | -3.01M | -3.19M |
| Income Before Tax | -2.05M | -3.19M | -3.47M | -4.16M | -3.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.05 | -3.19 | -3.47 | -4.16 | -3.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.05M | -3.19M | -3.47M | -4.16M | -3.16M |
| EBIT | -2.20M | -2.52M | -2.98M | -3.01M | -3.19M |
| EBITDA | -2.16M | -2.47M | -2.94M | -2.96M | -3.14M |
| EPS Basic | -0.08 | -0.11 | -0.12 | -0.15 | -0.12 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.05 | -0.07 | -0.07 |
| EPS Diluted | -0.08 | -0.12 | -0.12 | -0.15 | -0.12 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.05 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 134.22M | 131.84M | 127.98M | 123.98M | 120.15M |
| Average Diluted Shares Outstanding | 176.75M | 174.37M | 127.98M | 123.98M | 120.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |